CH EPL (R5)
1.0.0-ci-build - ci-build
CH EPL (R5)
1.0.0-ci-build - ci-build
CH EPL (R5), published by Federal Office of Public Health FOPH. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ci-build built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/bag-epl/bag-epl-fhir/ and changes regularly. See the Directory of published versions
Contents:
This page provides a list of the FHIR artifacts defined as part of this implementation guide.
These define constraints on FHIR resources for systems conforming to this implementation guide.
| CH EPL Organization |
Defines basic constraints and extensions on the Organization resource for use with other CH EPL resources |
| CH IDMP AdministrableProductDefinition |
Profile of the AdministrableProductDefinition resource for representing a medicinal product in the final form which is suitable for administering to a patient. |
| CH IDMP ClinicalUseDefinition Indication |
Profile of the ClinicalUseDefinition resource for representing an indication. |
| CH IDMP DocumentReference |
Profile of the DocumentReference resource for representing professional information and patient information as attachments. |
| CH IDMP ManufacturedItemDefinition |
Profile of the ManufacturedItemDefinition resource for representing the characteristics of a medicinal manufactured item as contained in a packaged medicinal product. |
| IDMP Bundle |
Profile of the Bundle resource for representing the set of resources collected into a single package. |
| IDMP Ingredient |
Profile of the Ingredient resource for representing the material used in the preparation of a medicinal/pharmaceutical product. |
| IDMP MedicinalProductDefinition |
Profile of the MedicinalProductDefinition resource for representing the detailed data of medicinal products. |
| IDMP PackagedProductDefinition |
Profile of the PackagedProductDefinition resource for representing a medically related item or items, in a container or package. |
| IDMP RegulatedAuthorization |
Profile of the RegulatedAuthorization resource for representing the market authorization of a (packaged) medicinal product. |
These define constraints on FHIR data types for systems conforming to this implementation guide.
| FOPH Dossier Number |
Identifier holding the Dossier number of FOPH |
| GLN Identifier |
Identifier holding a number for GLN (Global Location Number) |
| LOC Identifier |
Identifier holding a number for LocID (Location Identifier of the European Medicines Agency - Organisation Management System OMS) |
These define constraints on FHIR data types for systems conforming to this implementation guide.
| CH - EPL Full Limitation Text |
Extension for representing the full wording of the limitations used by FOPH |
| CH - EPL Product Price |
A set of information about the price of a drug |
| CH - EPL Regulated Authorization Limitation |
A limitation to an authorisation for reimbursement of a drug, for a certain indication. |
| CH - EPL Reimbursement SL |
A set of information about the reimbursement of a drug |
| CH - SMC Authorized Dose Form |
Extension for representing the authorized dose form |
These define sets of codes used by systems conforming to this implementation guide.
| CH - Authorisation Type |
Value Set for Authorisation Type in Switzerland used by FOPH |
| CH - Medicinal Product Name Type |
Value Set for the Medicinal Product Name Type used in Switzerland |
| CH - Other Characteristics Type |
Value Set for Other Characteristics |
| CH EPL - Gamme |
Value Set for the Gamme from ePL used by FOPH |
| CH EPL - Limitation Status |
Value Set for Limitierungsstatus from ePL used by FOPH |
| CH EPL - Listing Status |
Value Set for Listing Status from ePL used by FOPH |
| CH EPL - Other Characteristics Packaged Item |
Value Set for Other Characteristics of a Packaged Item from ePL used by FOPH |
| CH EPL - Price Type |
Value Set for Pricetype from ePL used by FOPH |
| CH EPL - Product Type |
Value Set for the Product Type from ePL used by FOPH |
| CH EPL - Reimbursement Status |
Value Set for Reimbursement Status from ePL used by FOPH |
| CH EPL - Type of Price Change |
Value Set for TypeofPriceChange from ePL used by FOPH |
| CH SMC - Additional Monitoring Indicator |
Value Set for the Additional Monitoring Indicator from SMC |
| CH SMC - Attached Document Type |
Value Set for the Legal Status of Supply from SMC |
| CH SMC - Authorisation Category |
Value Set for the Authorisation Category from SMC |
| CH SMC - Authorisation Status |
Value Set for the Authorisation Status from SMC |
| CH SMC - Authorised Pharmaceutical Dose Form |
Value Set for the Authorised Pharmaceutical Dose Form from SMC used by FOPH |
| CH SMC - Ingredient Role |
Value Set for the Ingredient Role from SMC |
| CH SMC - Legal Status of Supply |
Value Set for the Legal Status of Supply from SMC |
| CH SMC - Marketing Status |
Value Set for the Marketingstatus from SMC |
| CH SMC - Pediatric Use Indicator |
Value Set for the Pediatric Use Indicator from SMC |
| CH SMC - Special Precautions for Storage |
Value Set for the Special Precautions for Storage from SMC |
| CH SMC - Substance |
Value Set for the Substances from SMC |
| CH SMC - TherapeuticProductcode |
Value Set for the TherapeuticProductcode from SMC |
| EDQM - Combination Packaging |
Value Set for the Combination Packaging from EDQM used by SMC |
| EDQM - Combined Pharmaceutical Dose Form |
Value Set for the Combined Pharmaceutical Dose Froms from EDQM used by SMC |
| EDQM - Combined Term |
Value Set for the Combined Terms from EDQM used by SMC |
| EDQM - Packaging |
Value Set for the Packaging from EDQM used by SMC |
| EDQM - Pharmaceutical Dose Form |
Value Set for the Pharmaceutical Dose Form |
| EDQM - Route Of Administration |
Value Set for the Route Of Administration from EDQM |
| EDQM - Unit of Presentation |
Value Set for the Unit of Presentation from EDQM used by SMC |
| EMA - Domain |
Value Set for the Domain from EMA used by SMC |
| EMA - Intended Effect |
Value Set for the Intended Effect from EMA used by SMC |
| EMA - Shelf Life Type |
Value Set for the Shelf Life Type from EMA used by SMC |
These define new code systems used by systems conforming to this implementation guide.
| CH - Authorisation Type |
CH EPL - Standard Terms used in Switzerland (aggregations of codes of ValueSets Authorisation Type |
| CH - Medicinal Product Name Type |
CH - Standard Terms used in Switzerland (aggregations of codes of ValueSets Typ des Arzneimittelnamens) |
| CH - Other Characteristics Type |
CH - Standard Terms to define the different other characteristics |
| CH EPL - Gamme |
CH ePL - Code System for the Gamme from ePL used by FOPH |
| CH EPL - Limitation Status |
CH EPL - Standard Terms used in Switzerland (aggregations of codes of ValueSets Limitierungsstatus |
| CH EPL - Listing Status |
CH ePL - Standard Terms used in Switzerland (aggregations of codes of ValueSets Listungs Status |
| CH EPL - Other Characteristics Packaged Item |
CH ePL - Standard Terms used in Switzerland (aggregations of codes of ValueSets Other Characteristics of a Packaged Item |
| CH EPL - Price Type |
CH ePL - Standard Terms used in Switzerland (aggregations of codes of ValueSets Price Type |
| CH EPL - Product Type |
Code System for the Product Type from ePL used by FOPH |
| CH EPL - Reimbursement Status |
CH ePL - Standard Terms used in Switzerland (aggregations of codes of ValueSets Vergütungs Status |
| CH EPL - Type of Price Change |
CH EPL - Standard Terms used in Switzerland (aggregations of codes of ValueSets TypeofPriceChange |
| CH SMC - Additional Monitoring Indicator |
CH - Standard Terms used in Switzerland (aggregations of codes of ValueSets Additional Monitoring Indicator |
| CH SMC - Attached Document Type |
CH - Standard Terms used in Switzerland (aggregations of codes of ValueSets Typ des Anhangs) |
| CH SMC - Authorisation Category |
CH - Standard Terms used in Switzerland (aggregations of codes of ValueSets Authorisation Category) |
| CH SMC - Authorisation Status |
CH - Standard Terms used in Switzerland (aggregations of codes of ValueSets Zulassungsstatus) |
| CH SMC - Ingredient Role |
CH - Standard Terms used in Switzerland (aggregations of codes of ValueSets Funktion des Inhaltsstoffes) |
| CH SMC - Legal Status of Supply |
CH - Standard Terms used in Switzerland (aggregations of codes of ValueSets Abgabekategorie) |
| CH SMC - Marketing Status |
CH - Standard Terms used in Switzerland (aggregations of codes of ValueSets Vermarktungsstatus) |
| CH SMC - Pediatric Use Indicator |
CH - Standard Terms used in Switzerland (aggregations of codes of ValueSets Pediatric Use Indicator) |
| CH SMC - Special Precautions for Storage |
CH - Standard Terms used in Switzerland (aggregations of codes of ValueSets Besondere Vorsichtsmassnahmen für die Aufbewahrung) |
| CH SMC - Substance |
CH - Standard Terms used in Switzerland (aggregations of codes of ValueSets Substanzen) |
| CH SMC - TherapeuticProductcode |
CH - Standard Terms used in Switzerland (aggregations of codes of ValueSets TherapeuticProductcode) |
| EDQM - Standard Terms |
EDQM - Standard Terms used in Switzerland (see original codes system defined in https://standardterms.edqm.eu/#) |
| EMA - Domain |
CH - Standard Terms used in Switzerland (aggregations of codes of Value Set for the Domain from EMA used by SMC) |
| EMA - Intended Effect |
CH - Standard Terms used in Switzerland (aggregations of codes of Value Set for the Intended Effect from EMA used by SMC) |
| EMA - Shelf Life Type |
CH - Standard Terms used in Switzerland (aggregations of codes of Value Set for the Shelf Life Type from EMA used by SMC) |
These define identifier and/or code system identities used by systems conforming to this implementation guide.
| FOPH Dossier Number |
Identifier holding the Dossier number of FOPH |
| GLN Identifier |
Identifier holding a number for GLN (Global Location Number) |
| Global Trade Item Number |
GS1 defines trade items as products or services that are priced, ordered or invoiced at any point in the supply chain. |
| LOC Identifier |
Identifier holding a number for LocID (Location Identifier of the European Medicines Agency - Organisation Management System OMS) |
These are example instances that show what data produced and consumed by systems conforming with this implementation guide might look like.
| 5204201 |
ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk |
| 52042011 |
ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk |
| 5470402 |
ESTALIS Matrixpfl 50/250 24 Stk |
| 54704089 |
ESTALIS Matrixpfl 50/250 24 Stk |
| 66231001 |
KEYTRUDA Inf Konz 100 mg / 4 ml |
| 6623101 |
KEYTRUDA Inf Konz 100 mg / 4 ml |
| 67431001 |
TRIOGEN Kaps 250 mg Ds 100 Stk |
| 6743101 |
TRIOGEN Kaps 250 mg Ds 100 Stk |
| 67719001 |
CUPRIOR Filmtabl 150 mg 72 Stk |
| 6771901 |
CUPRIOR Filmtabl 150 mg 72 Stk |
| 67831001 |
ABRILADA Inj Lös 40 mg/0.8ml Fertpen 0.8 ml 1 Fertigpen |
| 67831001 |
ABRILADA Inj Lös 40 mg/0.8ml Fertpen 0.8 ml 2 Fertigpen |
| 6783101 |
ABRILADA Inj Lös 40 mg/0.8ml Fertpen 0.8 ml |
| 68793001 |
PAXLOVID Filmtabl 4x150mg/2x100mg |
| 6879301 |
PAXLOVID Filmtabl 4x150mg/2x100mg |
| ABRILADA Inj Lös 40 mg/0.8ml Fertpen 0.8 ml (Bundle) |
ABRILADA Inj Lös 40 mg/0.8ml Fertpen 0.8 ml: Example of a Bundle |
| Abrilada, Injektionslösung |
ABRILADA Inj Lös 40 mg/0.8ml Fertpen 0.8 ml: Example of a MedicinalProductDefinition (Medicinal Product) |
| Abrilada, Injektionslösung Fachinformation |
ABRILADA Inj Lös 40 mg/0.8ml Fertpen 0.8 ml |
| Abrilada, Injektionslösung Fachinformation |
ABRILADA Inj Lös 40 mg/0.8ml Fertpen 0.8 ml |
| CH-52042011 |
ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk: Example of a PackagedProductDefinition (Packaged Medicinal Product) |
| CH-54704089 |
ESTALIS Matrixpfl 50/250 24 Stk: Example of a PackagedProductDefinition (Packaged Medicinal Product) |
| CH-66231001 |
KEYTRUDA Inf Konz 100 mg / 4 ml: Example of a PackagedProductDefinition (Packaged Medicinal Product) |
| CH-67431001 |
TRIOGEN Kaps 250 mg Ds 100 Stk: Example of a PackagedProductDefinition (Packaged Medicinal Product) |
| CH-67831001 |
ABRILADA Inj Lös 40 mg/0.8ml Fertpen 1 x 0.8 ml: Example of a PackagedProductDefinition (Packaged Medicinal Product) |
| CH-67831002 |
ABRILADA Inj Lös 40 mg/0.8ml Fertpen 2 x 0.8 ml: Example of a PackagedProductDefinition (Packaged Medicinal Product) |
| CH-68291001 |
CUPRIOR Filmtabl 150 mg 72 Stk: Example of a PackagedProductDefinition (Packaged Medicinal Product) |
| CH-68793001 |
PAXLOVID Filmtabl 4x150mg/2x100mg: Example of a PackagedProductDefinition (Packaged Medicinal Product) |
| CUPRIOR Filmtabl 150 mg (Bundle) |
CUPRIOR Filmtabl 150 mg: Example of a Bundle |
| CUPRIOR Filmtabl 150 mg 72 Stk |
CUPRIOR Filmtabl 150 mg 72 Stk: Example of a MedicinalProductDefinition (Medicinal Product) |
| Cuprior, Filmtabletten Fachinformation |
CUPRIOR Filmtabl 150 mg 72 Stk |
| Cuprior, Filmtabletten Patienteninformation |
CUPRIOR Filmtabl 150 mg 72 Stk |
| ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk |
ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk: Example of a MedicinalProductDefinition (Medicinal Product) |
| ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk (Bundle) |
ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk: Example of a Bundle |
| ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk Fachinformation |
ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk |
| ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk Patienteninformation |
ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk |
| ESTALIS Matrixpfl 50/250 24 Stk |
ESTALIS Matrixpfl 50/250 24 Stk: Example of a MedicinalProductDefinition (Medicinal Product) |
| ESTALIS Matrixpfl 50/250 24 Stk (Bundle) |
ESTALIS Matrixpfl 50/250 24 Stk: Example of a Bundle |
| ESTALIS Matrixpfl 50/250 24 Stk Fachinformation |
ESTALIS Matrixpfl 50/250 24 Stk |
| ESTALIS Matrixpfl 50/250 24 Stk Patienteninformation |
ESTALIS Matrixpfl 50/250 24 Stk |
| Indication 10002556 |
ABRILADA Inj Lös 40 mg/0.8ml: Example of an ClinicalParticulars-Indication (Indication) |
| Indication 10003268 |
ABRILADA Inj Lös 40 mg/0.8ml: Example of an ClinicalParticulars-Indication (Indication) |
| Indication 10009900 |
ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk: Example of an ClinicalParticulars-Indication (Indication) |
| Indication 10019927 |
KEYTRUDA Inf Konz 100 mg / 4 ml: Example of an ClinicalParticulars-Indication (Indication) |
| Indication 10020041 |
ABRILADA Inj Lös 40 mg/0.8ml: Example of an ClinicalParticulars-Indication (Indication) |
| Indication 10021782 |
KEYTRUDA Inf Konz 100 mg / 4 ml: Example of an ClinicalParticulars-Indication (Indication) |
| Indication 10027400 |
KEYTRUDA Inf Konz 100 mg / 4 ml: Example of an ClinicalParticulars-Indication (Indication) |
| Indication 10028881 |
KEYTRUDA Inf Konz 100 mg / 4 ml: Example of an ClinicalParticulars-Indication (Indication) |
| Indication 10030247 |
ESTALIS Matrixpfl 50/250 24 Stk: Example of an ClinicalParticulars-Indication (Indication) |
| Indication 10031285 |
ESTALIS Matrixpfl 50/250 24 Stk: Example of an ClinicalParticulars-Indication (Indication) |
| Indication 10037153 |
ABRILADA Inj Lös 40 mg/0.8ml: Example of an ClinicalParticulars-Indication (Indication) |
| Indication 10037160 |
ABRILADA Inj Lös 40 mg/0.8ml: Example of an ClinicalParticulars-Indication (Indication) |
| Indication 10043971 |
KEYTRUDA Inf Konz 100 mg / 4 ml: Example of an ClinicalParticulars-Indication (Indication) |
| Indication 10045365 |
ABRILADA Inj Lös 40 mg/0.8ml: Example of an ClinicalParticulars-Indication (Indication) |
| Indication 10046851 |
ABRILADA Inj Lös 40 mg/0.8ml: Example of an ClinicalParticulars-Indication (Indication) |
| Indication 10061091 |
CUPRIOR Filmtabl 150 mg 72 Stk: Example of an ClinicalParticulars-Indication (Indication) and TRIOGEN Kaps 250 mg Ds 100 Stk: Example of an ClinicalParticulars-Indication (Indication) |
| Indication 10075566 |
KEYTRUDA Inf Konz 100 mg / 4 ml: Example of an ClinicalParticulars-Indication (Indication) |
| Indication 10084529 |
PAXLOVID Filmtabl 4x150mg/2x100mg: Example of an ClinicalParticulars-Indication (Indication) |
| Indication 10089182 |
ABRILADA Inj Lös 40 mg/0.8ml: Example of an ClinicalParticulars-Indication (Indication) |
| KEYTRUDA Inf Konz 100 mg / 4 ml |
KEYTRUDA Inf Konz 100 mg / 4 ml: Example of a MedicinalProductDefinition (Medicinal Product) |
| KEYTRUDA Inf Konz 100 mg / 4 ml (Bundle) |
KEYTRUDA Inf Konz 100 mg / 4 ml: Example of a Bundle |
| Keytruda, Konzentrat zur Herstellung einer Infusionslösung Fachinformation |
KEYTRUDA Inf Konz 100 mg / 4 ml |
| Limitation 156370009 |
ABRILADA Inj Lös 40 mg/0.8ml: Example of an ClinicalUseDefinition-Limitation (Indication) |
| Limitation 254837009 |
KEYTRUDA Inf Konz 100 mg / 4 ml: Example of an ClinicalUseDefinition-Limitation (Indication) |
| Limitation 34000006 |
ABRILADA Inj Lös 40 mg/0.8ml: Example of an ClinicalUseDefinition-Limitation (Indication) |
| Limitation 59393003 |
ABRILADA Inj Lös 40 mg/0.8ml: Example of an ClinicalUseDefinition-Limitation (Indication) |
| Limitation 64766004 |
ABRILADA Inj Lös 40 mg/0.8ml: Example of an ClinicalUseDefinition-Limitation (Indication) |
| Limitation 69896004 |
ABRILADA Inj Lös 40 mg/0.8ml: Example of an ClinicalUseDefinition-Limitation (Indication) |
| Limitation 79886009 |
CUPRIOR Filmtabl 150 mg 72 Stk: Example of an ClinicalUseDefinition-Limitation (Indication) |
| Limitation 840539006 |
PAXLOVID Filmtabl 4x150mg/2x100mg: Example of an ClinicalUseDefinition-Limitation (Indication) |
| Limitation 9014002 |
ABRILADA Inj Lös 40 mg/0.8ml: Example of an ClinicalUseDefinition-Limitation (Indication) |
| Limitation 9631008 |
ABRILADA Inj Lös 40 mg/0.8ml: Example of an ClinicalUseDefinition-Limitation (Indication) |
| MI Abrilada-40mg-Pre-Filled-Pen |
Manufactured Item definition for ABRILADA Inj Lös 40 mg/0.8ml Fertpen 0.8 ml |
| MI Budesonidum-2.3mg-Tablet |
Manufactured Item definition for Budesonidum 2.3mg tablet |
| MI Estradiol-hemihydrate-Norethisteroni-acetas-Transdermal-patch |
Manufactured Item definition for Estradiol-hemihydrate-and-Norethisteroni-acetas-Transdermal-patch |
| MI Nirmatrelvir-150mg-Tablet |
Manufactured Item definition for Nirmatrelvir 150mg Filmcoatedtablet |
| MI Pembrolizumab-100mg-Vial |
Manufactured Item definition for KEYTRUDA Inf Konz 100 mg / 4 ml |
| MI Ritonavirum-100mg-Tablet |
Manufactured Item definition for Ritonavirum 100mg Filmcoatedtablet |
| MI Solvent |
Manufactured Item definition for solvent |
| MI Trientinum-150mg-Tablet |
Manufactured Item definition for Trientinum 150 mg Film-coated tablet |
| MI Trientinum-250mg-Capsule |
Manufactured Item definition for Trientinum 250 mg Capsule |
| PAXLOVID Filmtabl 4x150mg/2x100mg |
PAXLOVID Filmtabl 4x150mg/2x100mg: Example of a MedicinalProductDefinition (Medicinal Product) |
| PAXLOVID Filmtabl 4x150mg/2x100mg (Bundle) |
PAXLOVID Filmtabl 4x150mg/2x100mg: Example of a Bundle |
| Paxlovid, Filmtabletten Patienteninformation |
PAXLOVID Filmtabl 4x150mg/2x100mg |
| PhP Abrilada-40mg-Pre-Filled-Pen |
Administrable Product of ABRILADA Inj Lös 40 mg/0.8ml Fertpen 0.8 ml |
| PhP Budesonidum-Suspension |
Administrable Product of Budesonidum Suspension |
| PhP Estradiol-hemihydrate and Norethisteroni-acetas Transdermal-patch |
Administrable Product of Estradiol-hemihydrate and Norethisteroni-acetas Transdermal-patch |
| PhP Pembrolizumab-100mg-Vial |
Administrable Product of KEYTRUDA Inf Konz 100 mg / 4 ml |
| PhP Trientinum-150mg-Tablet |
Administrable Product of Trientinum 150mg Film-coated tablet |
| PhP Trientinum-150mg-Tablet |
Administrable Product of Trientinum 150mg Film-coated tablet |
| PhP-Nirmatrelvir-150mg-Filmcoatedtablet |
Administrable Product of Paxlovid-Filmcoatedtablet |
| PhP-Ritonavirum-100mg-Filmcoatedtablet |
Administrable Product of Paxlovid-Filmcoatedtablet |
| Professional Information Paxlovid, Filmtabletten Fachinformation |
PAXLOVID Filmtabl 4x150mg/2x100mg |
| Reimbursement SL 17418 |
ESTALIS Matrixpfl 50/250 24 Stk: Example of an Regulated Authorization - Reimbursement Authorization |
| Reimbursement SL 17973 |
ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk: Example of an Regulated Authorization - Reimbursement Authorization |
| Reimbursement SL 20416 |
KEYTRUDA Inf Konz 100 mg / 4 ml: Example of an Regulated Authorization - Reimbursement Authorization |
| Reimbursement SL 21070 |
TRIOGEN Kaps 250 mg Ds 100 Stk: Example of an Regulated Authorization - Reimbursement Authorization |
| Reimbursement SL 21203 1 Pre-Filled Pen |
Abrilada-40mg-1-Pre-Filled-Pen: Example of an Regulated Authorization - Reimbursement Authorization |
| Reimbursement SL 21203 2 Pre-Filled Pen |
Abrilada-40mg-2-Pre-Filled-Pen: Example of an Regulated Authorization - Reimbursement Authorization |
| Reimbursement SL 21208 |
CUPRIOR Filmtabl 150 mg 72 Stk: Example of an Regulated Authorization - Reimbursement Authorization |
| Reimbursement SL 21529 |
PAXLOVID Filmtabl 4x150mg/2x100mg: Example of an Regulated Authorization - Reimbursement Authorization |
| TRIOGEN Kaps 250 mg Ds 100 Stk |
TRIOGEN Kaps 250 mg Ds 100 Stk: Example of a MedicinalProductDefinition (Medicinal Product) |
| TRIOGEN Kaps 250 mg Ds 100 Stk (Bundle) |
TRIOGEN Kaps 250 mg Ds 100 Stk: Example of a Bundle |
| Triogen, Kapseln Fachinformation |
TRIOGEN Kaps 250 mg Ds 100 Stk |
| Triogen, Kapseln Patienteninformation |
TRIOGEN Kaps 250 mg Ds 100 Stk |